Do you have plaque psoriasis?
If so, you may be interested to know that a doctor in your area is conducting a clinical study to assess the safety and effectiveness of a medication in patients with plaque psoriasis. In this study, patients will switch from Enbrel® to the study medication, which is FDA-approved to treat chronic severe plaque psoriasis but has not been studied in psoriasis patients who are switching treatments.
To qualify for participation in this research study, you must:
• Be between the ages of 18 and 75 years old
• Have been diagnosed with plaque psoriasis
Post new comment